Copellor auto 80mg Pen Injection contains an active component as ixekizumab. It is a prescription medication for certain inflammatory conditions, primarily moderate to severe plaque psoriasis and psoriatic arthritis. Severe plaque psoriasis is a chronic autoimmune skin condition characterized by thick, red, and scaly patches. At the same time, psoriatic arthritis is an inflammatory condition that affects the joints and is often associated with psoriasis. This medication belongs to a class of drugs called interleukin inhibitors. Copellor auto 80mg Pen Injection has been shown to have a rapid onset of action, with noticeable improvements in skin symptoms and joint pain often seen within the first few weeks of treatment. Copellor auto 80mg Pen Injection should not be used in individuals who have a known hypersensitivity or allergic reaction to the medication or any of its components. This medication may increase the risk of infections. Therefore, it is generally not recommended to start treatment with this medication in individuals with active infections, including localized or systemic infections. Live vaccines should not be administered concurrently with Copellor auto 80mg Pen Injection. In individuals with a history of HBV infection, the virus may reactivate during or after treatment with the use o this medication. Close monitoring and appropriate management strategies are necessary in these cases.